Zobrazeno 1 - 10
of 118
pro vyhledávání: '"J, Majoros"'
Autor:
Istvan J. Majoros, Paul E. Makidon, Jingga Morry, Rong Qi, Sascha N. Goonewardena, Hubert Marotte, Alisa E. Koch, Phil Campbell, Ingrid L. Bergin, James R. Baker, Michael A. Beer, Alina Kotlyar, Zhengyi Cao, Thommey P. Thomas, Shuai Zhang, Asish C. Misra
Publikováno v:
Journal of Biomedical Nanotechnology. 11:1431-1441
Generation 5 (G5) poly(amidoamide) (PAMAM) dendrimers are synthetic polymers that have been broadly applied as drug delivery carriers. Methotrexate (MTX), an anti-folate metabolite, has been successfully used as an anti-inflammatory drug to treat rhe
Autor:
Christopher V. Kelly, Yueyang Zhong, Douglas G. Mullen, Mark M. Banaszak Holl, Bradford G. Orr, Daniel Q. McNerny, Suyang Qin, Istvan J. Majoros, Alina Kotlyar, Stassi DiMaggio, James R. Baker, Thommey P. Thomas, Ankur Desai, Xue-Min Cheng
Publikováno v:
Bioconjugate Chemistry. 22:679-689
A modular dendrimer-based drug delivery platform was designed to improve upon existing limitations in single dendrimer systems. Using this modular strategy, a biologically active platform containing receptor mediated targeting and fluorescence imagin
Autor:
Thommey P. Thomas, Alina Kotlyar, Istvan J. Majoros, Douglas G. Mullen, James R. Baker, Mark M. Banaszak Holl
Publikováno v:
Biomacromolecules. 10:3207-3214
Poly(amidoamine) (PAMAM) dendrimers carrying different amounts of surface amino groups were synthesized and tested for their effects on cellular cytotoxicity, lysosomal pH, and mitochondria-dependent apoptosis. In KB cells, the PAMAM dendrimers were
Autor:
Anna U. Bielinska, Bradford G. Orr, Luz P. Blanco, Douglas G. Mullen, James R. Baker, Rahul Rattan, Mark M. Banaszak Holl, Istvan J. Majoros, Seungpyo Hong, Jennifer L. Peters, Xiangyang Shi
Publikováno v:
Bioconjugate Chemistry. 20:1503-1513
Generation 7 (G7) poly(amidoamine) (PAMAM) dendrimers with amine, acetamide, and carboxylate end groups were prepared to investigate polymer/cell membrane interactions in vitro. G7 PAMAM dendrimers were used in this study because higher-generation of
Publikováno v:
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 1:502-510
This paper provides a synopsis of the advancements made in advancing a dendrimer-based nanomedicine towards human clinical trials by the Michigan Nanotechnology Institute for Medicine and Biological Sciences. A brief description of the synthesis and
Publikováno v:
Journal of Computational and Theoretical Nanoscience. 6:54-60
Molecular dynamics simulations of nano-therapeutics as a final product and of all intermediates in the process of generating a multi-functional nano-therapeutic based on a poly(amidoamine) (PAMAM) dendrimer were performed along with chemical analyses
Publikováno v:
Macromolecules. 41:8372-8379
Recently developed multifunctional cancer therapeutic nano-device production is based on poly(amidoamine) PAMAM generation 5 (G5) dendrimer as a carrier 1-5. Scale up synthesis of this nano-device is limited because of long reaction sequence (12 reac
Publikováno v:
Journal of Computational and Theoretical Nanoscience. 4:1179-1187
Publikováno v:
Biomacromolecules. 8:13-18
Our previous studies have demonstrated the applicability of poly(amidoamine) (PAMAM) dendrimers as a platform for the targeted delivery of chemotherapeutic drugs both in vitro and in vivo. To monitor the rate and extent of cell-killing caused by the
Autor:
Karen J. Roelofs, James C. Stanley, Brenda S. Cho, James R. Baker, Gilbert R. Upchurch, Istvan J. Majoros, Peter K. Henke
Publikováno v:
Annals of the New York Academy of Sciences. 1085:294-305
In this study, the distribution of labeled dendrimers in native and aneurysmal rat aortic tissue was examined. Adult male rats underwent infrarenal aorta perfusion with generation 5 (G5) acetylated Alexa Fluor 488-conjugated dendrimers for varying le